82 CHAPTER 3 with the 5-minute drooling quotient in children with developmental disabilities. Dev Med Child Neurol 2012; 54: 1121–6. 18. Osailan SM, Proctor GB, McGurk M, Paterson KL. Intraoral duct ligation without inclusion of the parasympathetic nerve supply induces rat submandibular gland atrophy. Int J Exp Pathol 2006; 87: 41–8. 19. Shirley WP, Hill JS, Woolley AL, Wiatrak BJ. Success and complications of four-duct ligation for sialorrhea. Int J Pediatr Otorhinolaryngol 2003; 67: 1–6. 20. Stamataki S, Behar P, Brodsky L. Surgical management of drooling: clinical and caregiver satisfaction outcomes. Int J Pediatr Otorhinolaryngol 2008; 72: 1801–5. 21. Khan WU, Islam A, Fu A et al. Four-duct ligation for the treatment of sialorrhea in children. JAMA Otolaryngol Head Neck Surg 2016; 142: 278–83. 22. Martin TJ, Conley SF. Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngol Head Neck Surg 2007; 137: 54–8. 23. Scheffer AR, Erasmus C, van Hulst K, et al. Botulinum toxin versus submandibular duct relocation for severe drooling. Dev Med Child Neurol 2010; 52: 1038–42. 24. Gonzalez-L MD, Martinez C, Bori y Fortuny I, Suso-Vergara S. Factors in the efficacy, safety, and impact on quality of life for treatment of drooling with botulinum toxin type A in patients with cerebral palsy. Am J Phys Med Rehabil 2017; 96: 68–76. 25. Schroeder AS, Kling T, Huss K, et al. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence. Neuropediatrics 2012; 43: 27–36. 26. Puraviappan P, Dass DB, Narayanan P. Efficacy of relocation of submandibular duct in cerebral palsy patients with drooling. Asian J Surg 2007; 30: 209–15. 27. Greensmith AL, Johnstone BR, Reid SM, Hazard CJ, Johnson HM, Reddihough DS. Prospective analysis of the outcome of surgical management of drooling in the pediatric population: a 10-year experience. Plast Reconstr Surg 2005; 116: 1233–42. 28. Delsing CP, Cillessen E, Scheffer A, van Hulst K, Erasmus CE, van den Hoogen FJ. Bilateral submandibular gland excision for drooling: our experience in twenty-six children and adolescents. Clin Otolaryngol 2015; 40: 285–90. 29. Berini-Aytes L, Gay-Escoda C. Morbidity associated with removal of the submandibular gland. J Craniomaxillofac Surg 1992; 20: 216–9. 30. Springborg LK, Møller MN. Submandibular gland excision: long-term clinical outcome in 139 patients operated in a single institution. Eur Arch Otorhinolaryngol 2013; 270: 1441–6. 31. Jongerius PH, van Hulst K, van den Hoogen FJA, Rotteveel JJ. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy. J Pediatr Gastroenterol Nutr 2005; 41: 351–3. 32. Bekkers S, van Hulst K, Erasmus CE, Delsing CP, Scheffer ART, van den Hoogen FJA. An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities. J Neurol 2020; 267:1508-1515.
RkJQdWJsaXNoZXIy MjY0ODMw